Related Experiment Video
Updated: Nov 28, 2025

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
Published on: November 10, 2023
Coronavirus-associated kidney outcomes in COVID-19, SARS, and MERS: a meta-analysis and systematic review
Shoulian Zhou1, Jing Xu1, Cheng Xue1
1Division of Nephrology, Changzheng Hospital, Second Military Medical University, Shanghai, People's Republic of China.
Insights
Kidney injury is common in coronavirus infections like SARS, MERS, and COVID-19, significantly increasing mortality risk. Recognizing acute kidney injury (AKI) and chronic kidney disease (CKD) is crucial for better patient outcomes.
Area of Science:
- Nephrology
- Infectious Diseases
- Public Health
Background:
- Recent pandemics (SARS, MERS, COVID-19) caused severe respiratory distress syndrome (ARDS).
- Kidney-related complications were noted but required systematic evaluation across these viral outbreaks.
Purpose of the Study:
- To conduct a meta-analysis and systematic review of kidney outcomes in SARS, MERS, and COVID-19.
- To evaluate the incidence, prevalence, and mortality risk of acute and chronic kidney events.
- To investigate virus prevalence and mortality in hemodialysis patients.
Main Methods:
- Systematic search of published studies up to June 16, 2020.
- Meta-analysis of kidney-related outcomes in hospitalized patients with coronavirus infections.
- Evaluation of acute kidney injury (AKI), chronic kidney disease (CKD), and kidney replacement therapy (KRT) use and outcomes.
Main Results:
- Included 58 studies with 13,452 patients.
- New-onset AKI occurred in 12.5% and significantly increased mortality risk (OR=5.75).
- Urgent-start KRT (8.9%) and pre-existing CKD were associated with higher mortality.
- Hemodialysis patients had a 7.7% infection rate and 26.2% mortality.
Conclusions:
- Primary kidney involvement is frequent in coronavirus infections.
- AKI, CKD, and urgent-start KRT are major mortality risk factors.
- Recognizing these kidney issues is vital for reducing mortality and long-term morbidity.
Objectives:
A meta-analysis and systematic review was conducted on kidney-related outcomes of three recent pandemics: SARS, MERS, and COVID-19, which were associated with potentially fatal acute respiratory distress syndrome (ARDS).
Methods:
A search of all published studies until 16 June 2020 was performed. The incidence/prevalence and mortality risk of acute and chronic renal events were evaluated, virus prevalence, and mortality in preexisting hemodialysis patients was investigated.
Results:
A total of 58 eligible studies involving 13452 hospitalized patients with three types of coronavirus infection were included. The reported incidence of new-onset acute kidney injury (AKI) was 12.5% (95% CI: 7.6%-18.3%). AKI significantly increased the mortality risk (OR = 5.75, 95% CI 3.75-8.77, p < 0.00001) in patients with coronavirus infection. The overall rate of urgent-start kidney replacement therapy (urgent-start KRT) use was 8.9% (95% CI: 5.0%-13.8%) and those who received urgent-start KRT had a higher risk of mortality (OR = 3.43, 95% CI 2.02-5.85, p < 0.00001). Patients with known chronic kidney disease (CKD) had a higher mortality than those without CKD (OR = 1.97, 95% CI 1.56-2.49, p < 0.00001). The incidence of coronavirus infection was 7.7% (95% CI: 4.9%-11.1%) in prevalent hemodialysis patients with an overall mortality rate of 26.2% (95% CI: 20.6%-32.6%).
Conclusions:
Primary kidney involvement is common with coronavirus infection and is associated with significantly increased mortality. The recognition of AKI, CKD, and urgent-start KRT as major risk factors for mortality in coronavirus-infected patients are important steps in reducing future mortality and long-term morbidity in hospitalized patients with coronavirus infection.
Related Concept Videos
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury III: Clinical Manifestations
Chronic Kidney Disease II: Clinical Manifestations
Acute Kidney Injury I: Introduction
Chronic Kidney Disease I: Introduction

